Information de reference pour ce titreAccession Number: | 00003012-201110140-00009.
|
Author: | Makary, Samy; Voigt, Niels; Maguy, Ange; Wakili, Reza; Nishida, Kunihiro; Harada, Masahide; Dobrev, Dobromir; Nattel, Stanley
|
Institution: | From the Department of Medicine and Research Center (S.M., A.M., R.W., K.N., M.H., S.N.), Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada; Physiology Department, Faculty of Medicine, Suez Canal University, Egypt (S.M.); Department of Pharmacology and Therapeutics (S.N.), McGill University, Montreal, Quebec, Canada; Division of Experimental Cardiology (S.M., N.V., D.D.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Medicine I (R.W.), Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany; Second Department of Internal Medicine (K.N.), University of Toyama, Toyama, Japan.
|
Title: | |
Source: | Circulation Research. 109(9):1031-1043, October 14, 2011.
|
Abstract: | Rationale: Atrial fibrillation (AF) causes atrial-tachycardia remodeling (ATR), with enhanced constitutive acetylcholine-regulated K+ current (IKAChC) contributing to action potential duration shortening and AF promotion. The underlying mechanisms are unknown.
Objective: To evaluate the role of protein-kinase C (PKC) isoforms in ATR-induced IKAChC activation.
Methods and Results: Cells from ATR-dogs (400-bpm atrial pacing for 1 week) were compared to control dog cells. In vitro tachypaced (TP; 3 Hz) canine atrial cardiomyocytes were compared to parallel 1-Hz paced cells. IKAChC single-channel activity was assessed in cell-attached and cell-free (inside-out) patches. Protein expression was assessed by immunoblot. In vitro TP activated IKAChC, mimicking effects of in vivo ATR. Discrepant effects of PKC activation and inhibition between control and ATR cells suggested isoform-selective effects and altered PKC isoform distribution. Conventional PKC isoforms (cPKC; including PKC[alpha]) inhibited, whereas novel isoforms (including PKC[epsilon]) enhanced, acetylcholine-regulated K+ current (IKACh) in inside-out patches. TP and ATR downregulated PKC[alpha] (by 33% and 37%, respectively) and caused membrane translocation of PKC[epsilon], switching PKC predominance to the stimulatory novel isoform. TP increased [Ca2+]i at 2 hours by 30%, with return to baseline at 24 hours. Buffering [Ca2+]i during TP with the cell-permeable Ca2+ chelator BAPTA-AM (1 [mu]mol/L) or inhibiting the Ca2+-dependent protease calpain with PD150606 (20 [mu]mol/L) prevented PKC[alpha] downregulation and TP enhancement of IKAChC. PKC[epsilon] inhibition with a cell-permeable peptide inhibitor suppressed TP/ATR-induced IKAChC activation, whereas cPKC inhibition enhanced IKAChC activity in 1-Hz cells.
Conclusions: PKC isoforms differentially modulate IKACh, with conventional Ca2+-dependent isoforms inhibiting and novel isoforms enhancing activity. ATR causes a rate-dependent PKC isoform switch, with Ca2+/calpain-dependent downregulation of inhibitory PKC[alpha] and membrane translocation of stimulatory PKC[epsilon], enhancing IKAChC. These findings provide novel insights into mechanisms underlying IKAChC dysregulation in AF.
(C) 2011 American Heart Association, Inc.
|
Author Keywords: | atrial tachycardia; protein kinase C isoforms; remodeling.
|
References: | 1. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
2. Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, Knaut M, Ravens U. The G protein-gated potassium current IKACh is constitutively active in patients with chronic atrial fibrillation. Circulation. 2005;112:3697-3706.
3. Ehrlich JR, Cha TJ, Zhang L, Chartier D, Villeneuve L, Hebert TE, Nattel S. Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium. J Physiol. 2004;557(Pt 2):583-597.
4. Cha TJ, Ehrlich JR, Chartier D, Qi XY, Xiao L, Nattel S. Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias. Circulation. 2006;113:1730-1737.
5. Voigt N, Maguy A, Yeh YH, Qi X, Ravens U, Dobrev D, Nattel S. Changes in IKACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res. 2008;77:35-43.
6. Pandit SV, Berenfeld O, Anumonwo JM, Zaritski RM, Kneller J, Nattel S, Jalife J. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J. 2005;88:3806-3821.
7. Heidbuchel H, Callewaert G, Vereecke J, Carmeliet E. ATP-dependent activation of atrial muscarinic K+ channels in the absence of agonist and G-nucleotides. Pflugers Arch. 1990;416:213-215.
8. Kaibara M, Nakajima T, Irisawa H, Giles W. Regulation of spontaneous opening of muscarinic K+ channels in rabbit atrium. J Physiol. 1991;433:589-613.
9. Medina I, Krapivinsky G, Arnold S, Kovoor P, Krapivinsky L, Clapham DE. A switch mechanism for G beta gamma activation of IKACh. J Biol Chem. 2000;275:29709-29716.
10. Voigt N, Friedrich A, Bock M, Wettwer E, Christ T, Knaut M, Strasser RH, Ravens U, Dobrev D. Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IKACh channels in patients with chronic atrial fibrillation. Cardiovasc Res. 2007;74:426-437.
11. Shinagawa K, Mitamura H, Ogawa S, Nattel S. Effects of inhibiting Na+/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Cardiovasc Res. 2002;54:438-446.
12. Cha TJ, Ehrlich JR, Zhang L, Nattel S. Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure. Circulation. 2004;110:1520-1526.
13. Brundel BJ, Kampinga HH, Henning RH. Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc Res. 2004;62:521-528.
14. Ron D, Luo J, Mochly-Rosen D. C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo. J Biol Chem. 1995;270:24180-24187.
15. Yedovitzky M, Mochly-Rosen D, Johnson JA, Gray MO, Ron D, Abramovitch E, Cerasi E, Nesher R. Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells. J Biol Chem. 1997;272:1417-1420.
16. Voigt N, Makary S, Nattel S, Dobrev D. Voltage-clamp-based methods for the detection of constitutively active acetylcholine-gated IKACh channels in the diseased heart. Methods Enzymol. 2010;484:653-675.
17. Shui Z, Boyett MR, Zang WJ. ATP-dependent desensitization of the muscarinic K+ channel in rat atrial cells. J Physiol. 1997;505:77-93.
18. Huang CL, Feng S, Hilgemann DW. Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature. 1998;391:803-806.
19. Liu GX, Derst C, Schlichthorl G, Heinen S, Seebohm G, Bruggemann A, Kummer W, Veh RW, Daut J, Preisig-Muller R. Comparison of cloned Kir2 channels with native inward rectifier K+ channels from guinea-pig cardiomyocytes. J Physiol. 2001;532:115-126.
20. Toda H, Ding WG, Yasuda Y, Toyoda F, Ito M, Matsuura H, Horie M. Stimulatory action of protein kinase C(epsilon) isoform on the slow component of delayed rectifier K+ current in guinea-pig atrial myocytes. Br J Pharmacol. 2007;150:1011-1021.
21. Qi XY, Yeh YH, Xiao L, Burstein B, Maguy A, Chartier D, Villeneuve LR, Brundel BJ, Dobrev D, Nattel S. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res. 2008;103:845-854.
22. Zhang L, Lee JK, John SA, Uozumi N, Kodama I. Mechanosensitivity of GIRK channels is mediated by protein kinase C-dependent channel-phosphatidylinositol 4,5-bisphosphate interaction. J Biol Chem. 2004;279:7037-7047.
23. Yeh YH, Ehrlich JR, Qi X, Hebert TE, Chartier D, Nattel S. Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes. Cardiovasc Res. 2007;74:406-415.
24. Rybin VO, Guo J, Gertsberg Z, Feinmark SJ, Steinberg SF. Phorbol 12-myristate 13-acetate-dependent protein kinase C delta-Tyr311 phosphorylation in cardiomyocyte caveolae. J Biol Chem. 2008;283:17777-17788.
25. Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev. 2008;88:1341-1378.
26. Mao J, Wang X, Chen F, Wang R, Rojas A, Shi Y, Piao H, Jiang C. Molecular basis for the inhibition of G protein-coupled inward rectifier K+ channels by protein kinase C. Proc Natl Acad Sci U S A. 2004;101:1087-1092.
27. Nikolov EN, Ivanova-Nikolova TT. Coordination of membrane excitability through a GIRK1 signaling complex in the atria. J Biol Chem. 2004;279:23630-23636.
28. Rybin VO, Guo J, Sabri A, Elouardighi H, Schaefer E, Steinberg SF. Stimulus-specific differences in protein kinase C delta localization and activation mechanisms in cardiomyocytes. J Biol Chem. 2004;279:19350-19361.
29. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415:219-226.
30. Brundel BJ, Ausma J, van Gelder IC, Van der Want JJ, van Gilst WH, Crijns HJ, Henning RH. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res. 2002;54:380-389.
31. Wang KK, Nath R, Posner A, Raser KJ, Buroker-Kilgore M, Hajimohammadreza I, Probert A W Jr, Marcoux FW, Ye Q, Takano E, Hatanaka M, Maki M, Caner H, Collins JL, Fergus A, Lee KS, Lunney EA, Hays SJ, Yuen P. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc Natl Acad Sci U S A. 1996;93:6687-6692.
32. Machida T, Hashimoto N, Kuwahara I, Ogino Y, Matsuura J, Yamamoto W, Itano Y, Zamma A, Matsumoto R, Kamon J, Kobayashi T, Ishiwata N, Yamashita T, Ogura T, Nakaya H. Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:94-102.
33. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res. 1999;44:121-131.
34. Dobrev D, Graf E, Wettwer E, Himmel HM, Hala O, Doerfel C, Christ T, Schuler S, Ravens U. Molecular basis of downregulation of G-protein-coupled inward rectifying K+ current IKACh in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced IKACh and muscarinic receptor-mediated shortening of action potentials. Circulation. 2001;104:2551-2557.
35. Dobrev D, Wettwer E, Kortner A, Knaut M, Schuler S, Ravens U. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res. 2002;54:397-404.
36. Cha TJ, Ehrlich JR, Zhang L, Chartier D, Leung TK, Nattel S. Atrial tachycardia remodeling of pulmonary vein cardiomyocytes: comparison with left atrium and potential relation to arrhythmogenesis. Circulation. 2005;111:728-735.
37. Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res. 1997;80:772-781.
38. Otero AS, Xu L, Ni Y, Szabo G. Receptor-independent activation of atrial muscarinic potassium channels in the absence of nucleotides. J Biol Chem. 1998;273:28868-28872.
39. Rishal I, Porozov Y, Yakubovich D, Varon D, Dascal N. Gbetagamma-dependent and Gbetagamma-independent basal activity of G protein-activated K+ channels. J Biol Chem. 2005;280:16685-16694.
40. Rubinstein M, Peleg S, Berlin S, Brass D, Dascal N. Galphai3 primes the G protein-activated K+ channels for activation by coexpressed Gbetagamma in intact Xenopus oocytes. J Physiol. 2007;581:17-32.
41. Hill JJ, Peralta EG. Inhibition of a Gi-activated potassium channel (GIRK1/4) by the Gq-coupled m1 muscarinic acetylcholine receptor. J Biol Chem. 2001;276:5505-5510.
42. Konopatskaya O, Poole AW. Protein kinase Calpha: disease regulator and therapeutic target. Trends Pharmacol Sci. 2010;31:8-14.
43. Sabri A, Steinberg SF. Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol Cell Biochem. 2003;251:97-101.
44. Liu Q, Chen X, Macdonnell SM, Kranias EG, Lorenz JN, Leitges M, Houser SR, Molkentin JD. Protein kinase C[alpha], but not PKC[beta] or PKC[delta], regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ Res. 2009;105:194-200.
45. Cardin S, Libby E, Pelletier P, Le Bouter S, Shiroshita-Takeshita A, Le Meur N, Leger J, Demolombe S, Ponton A, Glass L, Nattel S. Contrasting gene expression profiles in two canine models of atrial fibrillation. Circ Res. 2007;100:425-433.
46. Nattel S, Carlsson L. Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov. 2006;5:1034-1049.
47. Vlahos CJ, McDowell SA, Clerk A. Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov. 2003;2:99-113.
48. Mackay K, Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J Mol Cell Cardiol. 2001;33:1301-1307.
49. Schechtman D, Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene. 2001;20:6339-6347.
50. Hocini M, Nault I, Wright M, Veenhuyzen G, Narayan SM, Jais P, Lim KT, Knecht S, Matsuo S, Forclaz A, Miyazaki S, Jadidi A, O'Neill MD, Sacher F, Clementy J, Haissaguerre M. Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol. 2010;55:1007-1016.
|
Language: | English.
|
Document Type: | Cellular Biology.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0009-7330
|
NLM Journal Code: | daj, 0047103
|
DOI Number: | https://dx.doi.org/10.1161/CIRCR...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|